Index -
P/E -
EPS (ttm) -1.17
Insider Own 16.11%
Shs Outstand 24.00M
Perf Week 7.48%
Market Cap 2.20B
Forward P/E 17.57
EPS next Y 5.20
Insider Trans -1.74%
Shs Float 20.25M
Perf Month -7.10%
Income -28.04M
PEG -
EPS next Q 1.22
Inst Own 92.38%
Short Float / Ratio 6.29% / 3.90
Perf Quarter -36.95%
Sales 2.25B
P/S 0.98
EPS this Y -2.06%
Inst Trans -3.46%
Short Interest 1.27M
Perf Half Y -50.48%
Book/sh 86.93
P/B 1.05
EPS next Y -18.81%
ROA -0.64%
Target Price 130.00
Perf Year -42.64%
Cash/sh 8.24
P/C 11.08
EPS next 5Y 16.00%
ROE -1.36%
52W Range 78.28 - 212.43
Perf YTD -42.00%
Dividend -
P/FCF -
EPS past 5Y -
ROI -0.75%
52W High -57.00%
Beta 0.63
Dividend % -
Quick Ratio 0.98
Sales past 5Y 15.12%
Gross Margin 31.82%
52W Low 16.68%
ATR 4.14
Employees 14500
Current Ratio 2.62
Sales Q/Q -7.88%
Oper. Margin 2.29%
RSI (14) 49.18
Volatility 4.95% 5.25%
Optionable Yes
Debt/Eq 0.82
EPS Q/Q 153.77%
Profit Margin -1.25%
Rel Volume 1.47
Prev Close 87.76
Shortable Yes
LT Debt/Eq 0.79
Earnings Nov 06 AMC
Payout -
Avg Volume 326.77K
Price 91.34
Recom 1.67
SMA20 4.43%
SMA50 -10.29%
SMA200 -39.72%
Volume 479,129
Change 4.08%
Date
Action
Analyst
Rating Change
Price Target Change
Nov-08-22 Downgrade
Raymond James
Outperform → Mkt Perform
Mar-31-20 Upgrade
CJS Securities
Market Perform → Market Outperform
Mar-18-20 Upgrade
KeyBanc Capital Markets
Sector Weight → Overweight
$206
Aug-08-19 Downgrade
Raymond James
Strong Buy → Outperform
Oct-17-17 Initiated
KeyBanc Capital Mkts
Sector Weight
Jun-20-17 Downgrade
Sidoti
Buy → Neutral
Mar-11-16 Initiated
Gabelli & Co
Buy
$128
Nov-06-15 Reiterated
ROTH Capital
Buy
$124 → $130
Aug-11-15 Reiterated
ROTH Capital
Buy
$102 → $124
May-06-15 Reiterated
ROTH Capital
Buy
$96 → $102
Feb-10-15 Reiterated
ROTH Capital
Buy
$82 → $96
Nov-11-14 Upgrade
ROTH Capital
Neutral → Buy
$56 → $82
May-09-13 Downgrade
The Benchmark Company
Buy → Hold
Sep-27-12 Reiterated
The Benchmark Company
Buy
$60 → $69
Apr-12-12 Initiated
The Benchmark Company
Buy
$60
Sep-26-11 Reiterated
Ticonderoga
Buy
$52 → $49
Oct-29-09 Initiated
C.K. Cooper
Buy
$45
Oct-08-09 Initiated
Roth Capital
Hold
$40
Mar-05-09 Initiated
Northland Securities
Outperform
May-02-08 Initiated
Jesup & Lamont
Buy
$35
Show Previous Ratings
Nov-27-23 06:28PM
Nov-07-23 10:36AM
Nov-06-23 11:37PM
05:23PM
05:17PM
(Associated Press Finance)
04:05PM
Loading…
04:05PM
Oct-27-23 09:06PM
Oct-23-23 08:30AM
Sep-25-23 08:40AM
Sep-12-23 01:01AM
Sep-05-23 08:30AM
Sep-04-23 09:34AM
Aug-29-23 08:00AM
Aug-09-23 07:01AM
Aug-08-23 07:36PM
(Morningstar Research) -16.59%
06:31AM
Loading…
06:31AM
(Thomson Reuters StreetEvents)
Aug-07-23 08:13PM
06:40PM
05:31PM
04:05PM
Jul-24-23 08:30AM
Jun-21-23 08:00PM
Jun-20-23 05:13PM
May-10-23 06:09AM
May-09-23 05:25PM
(Morningstar Research) +13.64%
05:57AM
(Thomson Reuters StreetEvents)
May-08-23 05:35PM
04:29PM
04:05PM
Apr-26-23 08:00PM
07:56PM
Loading…
Apr-24-23 07:56PM
08:30AM
Apr-11-23 07:07AM
Mar-29-23 09:47AM
Mar-15-23 05:55PM
Mar-09-23 08:30AM
Mar-02-23 05:44AM
Mar-01-23 07:11PM
05:15AM
Feb-28-23 11:05AM
06:31AM
(Thomson Reuters StreetEvents)
Feb-27-23 06:15PM
04:05PM
Feb-26-23 08:04AM
Feb-21-23 08:30AM
Feb-13-23 08:30AM
Feb-08-23 08:00AM
Jan-23-23 08:55AM
Jan-20-23 07:21PM
(Morningstar Research) +5.83%
Dec-19-22 08:30AM
Dec-03-22 07:28AM
Nov-07-22 06:35PM
04:05PM
Nov-06-22 07:21AM
Nov-01-22 09:00AM
Oct-31-22 04:01PM
Oct-07-22 10:08AM
Oct-06-22 08:30AM
Sep-26-22 08:18AM
Sep-08-22 08:30AM
Aug-09-22 03:15PM
Aug-08-22 06:15PM
04:05PM
Jul-19-22 08:30AM
Jun-18-22 08:51AM
May-19-22 08:05AM
May-11-22 04:12PM
May-09-22 05:45PM
04:05PM
06:07AM
May-06-22 03:18AM
May-05-22 02:52AM
May-04-22 03:05AM
Apr-20-22 08:30AM
03:35AM
Apr-19-22 07:51AM
02:57AM
Apr-14-22 02:37AM
Apr-13-22 06:54AM
Apr-12-22 02:31AM
Apr-11-22 05:04AM
Apr-08-22 02:37AM
Mar-24-22 08:03AM
Mar-23-22 12:00PM
09:40AM
06:53AM
Mar-22-22 12:45PM
Mar-14-22 08:30AM
Mar-10-22 12:48PM
12:17PM
Mar-05-22 08:42AM
08:00AM
(Investor's Business Daily)
Mar-04-22 09:40AM
Mar-03-22 12:45PM
Mar-02-22 08:30AM
Feb-24-22 06:20PM
04:05PM
Feb-17-22 03:02PM
Feb-07-22 02:29PM
Feb-04-22 08:30AM
ICU Medical, Inc. engages in the development, manufacture, and sale of innovative medical devices used in vascular therapy and critical care applications. Its product portfolio includes intravenous smart pumps, sets, connectors, closed transfer devices for hazardous drugs, cardiac monitoring systems, IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needle-free connectors. The company was founded by George A. Lopez in 1984 and is headquartered in San Clemente, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Woolson Daniel VP, GM-Infusion Capital Dec 01 Sale 88.03 1,729 152,196 9,877 Dec 01 05:08 PM Voigtlander Christian B. Chief Operating Officer Sep 08 Sale 129.04 6,850 883,930 13,603 Sep 11 12:27 PM Jain Vivek Chairman and CEO Jul 12 Option Exercise 58.79 30,000 1,763,700 53,677 Jul 14 05:36 PM Jain Vivek Chairman and CEO Jul 12 Sale 180.02 30,000 5,400,720 23,677 Jul 14 05:36 PM Jain Vivek Chairman and CEO Jun 14 Option Exercise 58.79 30,000 1,763,700 31,840 Jun 15 10:22 AM Jain Vivek Chairman and CEO Jun 14 Sale 188.67 30,000 5,660,086 23,677 Jun 15 10:22 AM FINNEY ELISHA W Director Jun 07 Sale 190.41 194 36,940 1,481 Jun 07 04:26 PM KENNEDY KOLLEEN T Director May 17 Option Exercise 0.00 485 0 614 May 18 12:51 PM Hoffmeister David F Director May 17 Option Exercise 0.00 485 0 2,079 May 18 12:46 PM FINNEY ELISHA W Director May 17 Option Exercise 0.00 485 0 1,675 May 18 12:41 PM Abbey Donald Director May 17 Option Exercise 0.00 485 0 2,079 May 18 12:37 PM Hernandez Laurie Director May 17 Option Exercise 0.00 485 0 937 May 18 12:19 PM Greenberg David C. Director May 17 Option Exercise 0.00 485 0 4,089 May 18 12:15 PM Sanzone Virginia Ruth VP, General Counsel Apr 11 Sale 175.00 250 43,750 4,678 Apr 11 02:11 PM Sanzone Virginia Ruth VP, General Counsel Apr 05 Sale 170.00 458 77,860 4,928 Apr 05 05:07 PM Sanzone Virginia Ruth VP, General Counsel Mar 08 Option Exercise 0.00 2,272 0 6,582 Mar 08 05:06 PM Woolson Daniel VP, GM-Infusion Capital Mar 08 Option Exercise 0.00 2,020 0 12,500 Mar 08 05:09 PM Voigtlander Christian B. Chief Operating Officer Mar 08 Option Exercise 0.00 2,209 0 21,616 Mar 08 04:59 PM Jain Vivek Chairman and CEO Mar 08 Option Exercise 0.00 2,525 0 25,091 Mar 08 04:56 PM Bonnell Brian Michael Chief Financial Officer Mar 08 Option Exercise 0.00 2,209 0 13,578 Mar 08 04:52 PM Bonnell Brian Michael Chief Financial Officer Mar 07 Option Exercise 0.00 2,145 0 12,498 Mar 08 04:52 PM Jain Vivek Chairman and CEO Mar 07 Option Exercise 0.00 3,218 0 24,260 Mar 08 04:56 PM Voigtlander Christian B. Chief Operating Officer Mar 07 Option Exercise 0.00 2,145 0 20,536 Mar 08 04:59 PM Woolson Daniel VP, GM-Infusion Capital Mar 07 Option Exercise 0.00 965 0 10,908 Mar 08 05:09 PM Sanzone Virginia Ruth VP, General Counsel Mar 07 Option Exercise 0.00 1,072 0 4,874 Mar 08 05:06 PM Sanzone Virginia Ruth VP, General Counsel Mar 06 Option Exercise 0.00 1,595 0 4,641 Mar 08 05:06 PM Woolson Daniel VP, GM-Infusion Capital Mar 06 Option Exercise 0.00 1,417 0 10,569 Mar 08 05:09 PM Voigtlander Christian B. Chief Operating Officer Mar 06 Option Exercise 0.00 10,296 0 22,260 Mar 08 04:59 PM Jain Vivek Chairman and CEO Mar 06 Option Exercise 0.00 11,767 0 26,303 Mar 08 04:56 PM Bonnell Brian Michael Chief Financial Officer Mar 06 Option Exercise 0.00 10,296 0 14,957 Mar 08 04:52 PM Woolson Daniel VP, GM-Infusion Capital Feb 02 Sale 200.00 1,731 346,200 9,152 Feb 02 02:57 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite